Home/Filings/4/0001488774-26-000002
4//SEC Filing

Clifton R. LaDuane 4

Accession 0001488774-26-000002

CIK 0001434647other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:18 PM ET

Size

13.0 KB

Accession

0001488774-26-000002

Insider Transaction Report

Form 4
Period: 2025-12-31
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-31+140,667192,028 total
  • Tax Payment

    Common Stock

    2025-12-31$8.96/sh48,513$434,676143,515 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-12-3186,6670 total
    Common Stock (86,667 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-12-3134,0000 total
    Common Stock (34,000 underlying)
  • Exercise/Conversion

    Performance Stock Unit

    2025-12-3120,0000 total
    Common Stock (20,000 underlying)
Footnotes (5)
  • [F1]Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025.
  • [F2]Shares withheld to cover withholding taxes for the vested restricted stock units and performance stock units.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F4]The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.
  • [F5]Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.

Issuer

ZEVRA THERAPEUTICS, INC.

CIK 0001434647

Entity typeother

Related Parties

1
  • filerCIK 0001488774

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:18 PM ET
Size
13.0 KB